Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada.

@article{Krahn2005PotentialCO,
  title={Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada.},
  author={Murray D. Krahn and Ava A. John-Baptiste and Qilong Yi and Andrea Doria and Robert S. Remis and Paul Ritvo and Samuel Friedman},
  journal={Vaccine},
  year={2005},
  volume={23 13},
  pages={1549-58}
}
Hepatitis C virus (HCV) vaccine development remains at an early stage. We explored the economic and health consequences of potential HCV vaccines by comparing universal vaccination with a hepatitis C vaccine to no vaccination in two groups: (1) injecting drug users (IDU); (2) all 12 year olds, using a Markov cohort simulation. Among IDUs, vaccination would… CONTINUE READING